BioCentury
ARTICLE | Clinical News

AdnaTest BreastCancer: Post-marketing study data

November 16, 2009 8:00 AM UTC

Researchers at University Hospital Essen and University Hospital of Tuebingen reported that AdnaTest BreastCancer detected an EMT marker and ALDH1 in 62% and 69%, respectively, of 69 blood samples tha...